Ultragenyx Pharmaceutical
RARE
#4547
Rank
โ‚น247.46 B
Marketcap
โ‚น2,510
Share price
2.29%
Change (1 day)
-2.12%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: โ‚น247.46 Billion

As of August 2026 Ultragenyx Pharmaceutical has a market cap of โ‚น247.46 Billion. This makes Ultragenyx Pharmaceutical the world's 4547th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น247.46 B-16.43%
2025โ‚น296.11 B-13.91%
2024โ‚น343.96 B5.22%
2023โ‚น326.89 B21.63%
2022โ‚น268.77 B-37%
2021โ‚น426.62 B-36.3%
2020โ‚น669.75 B280.2%
2019โ‚น176.15 B13.92%
2018โ‚น154.62 B22.6%
2017โ‚น126.12 B-35.4%
2016โ‚น195.22 B-32.65%
2015โ‚น289.86 B226.38%
2014โ‚น88.81 B

End of Day market cap according to different sources

On Aug 24th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

โ‚น241.91 Billion
by Nasdaq info icon info icon
โ‚น241.91 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
โ‚น98.90 B-60.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น78.17 B-68.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น434.06 B 75.41%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.218 T 392.58%๐Ÿ‡บ๐Ÿ‡ธ USA